抗菌达洛巴克的新型基因工程衍生物支持它们在开发抗生素方面的潜力
Carsten E Seyfert1,2, Alison V Müller1,2, Danica J Walsh1,2
1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Saarland University Department of Pharmacy, Saarbrücken 66123, Germany.
工程双循环达洛巴克因通过向外膜蛋白BamaA,对抗格拉姆阴性病原体表现出强烈的活性. 这些新型化合物对世卫组织优先病原体和多药耐药临床分离物具有高度有效性.
科学领域:
- 合成生物学和药物化学
- 发现抗微生物药物发现.
- 格拉姆阴性细菌感染
背景情况:
- 达罗巴克是一种有前途的新型抗生素,向格拉姆阴性细菌.
- 对外膜蛋白BamaA的修改是达洛巴克作用机制的关键.
- 现有的达洛巴克显示出显著的,但可以改进的效力.
研究的目的:
- 研究达洛巴克22 (D22) 在位置2,4和5的结构驱动生物合成修饰.
- 为了增强达罗巴克丁的生物活性和抗葛兰氏阴性病原体的功效.
- 评估新型达洛巴克丁与优先病原体和多药耐药分离物相对应.
主要方法:
- 双循环达洛巴克的生物合成工程.
- 结构导向药物设计和D22.22的修改.
- 抗菌活性测定和用BamA确定解离常数.
- 关于化合物的ADMET分析.
主要成果:
- 新型达洛巴克与原生药物相比,对抗格拉姆阴性病原体的功效增加了多达128倍.
- 修改后的达洛巴克显示出对世界卫生组织优先病原体的高活性.
- 化合物D22和D69显示出有前途的ADMET配置文件和对抗多药耐药临床隔离物的强有力的活性.
结论:
- 由结构驱动的修改显著增强了达罗巴克的抗菌功效和频谱.
- 达罗巴克仍然是一个非常有前途的抗生素类别,用于对抗格兰氏阴性感染.
- 由于D22和D69的强大活性和有利性质,因此需要进一步开发D22.
更多相关视频
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
08:23Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
相关概念视频
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Recombinant DNA
